Cargando…

The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors

BACKGROUND: The insulin receptor (INSR) and the insulin growth factor 1 receptor (IGF1R) play important roles in the etiology of both diabetes mellitus and breast cancer. We aimed to evaluate the expression of hormone and insulin-related proteins within or related to the PI3K and MAPK pathway in bre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bronsveld, Heleen K., De Bruin, Marie L., Wesseling, Jelle, Sanders, Joyce, Hofland, Ingrid, Jensen, Vibeke, Bazelier, Marloes T., ter Braak, Bas, de Boer, Anthonius, Vestergaard, Peter, Schmidt, Marjanka K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389252/ https://www.ncbi.nlm.nih.gov/pubmed/29486734 http://dx.doi.org/10.1186/s12885-018-4072-8

Ejemplares similares

Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence
por: Bronsveld, Heleen K, et al.
Publicado: (2015)

CARING (CAncer Risk and INsulin analoGues): The Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants - A Systematic Review and a Meta-Analysis
por: Starup-Linde, Jakob, et al.
Publicado: (2013)

Use of Insulin and Insulin Analogs and Risk of Cancer — Systematic Review and Meta-Analysis of Observational Studies
por: Karlstad, Øystein, et al.
Publicado: (2014)

Diabetes and Breast Cancer Subtypes
por: Bronsveld, Heleen K., et al.
Publicado: (2017)

Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study
por: But, Anna, et al.
Publicado: (2017)

Use of Metformin and Survival of Diabetic Women with Breast Cancer
por: Peeters, Paul J.H.L., et al.
Publicado: (2013)

Insulin glargine use and breast cancer risk: Associations with cumulative exposure
por: Peeters, Paul J. H. L., et al.
Publicado: (2016)

Alternative signaling network activation through different insulin receptor family members caused by pro-mitogenic antidiabetic insulin analogues in human mammary epithelial cells
por: ter Braak, Bas, et al.
Publicado: (2015)

A Follow-up Study on BMI-SDS and Insulin Resistance in Overweight and Obese Children at Risk for Type 2 Diabetes Mellitus
por: Fazeli Farsani, Soulmaz, et al.
Publicado: (2015)

Data management and data analysis techniques in pharmacoepidemiological studies using a pre‐planned multi‐database approach: a systematic literature review
por: Bazelier, Marloes T., et al.
Publicado: (2015)

Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production
por: ter Braak, Bas, et al.
Publicado: (2017)

Risk of bladder cancer in patients with diabetes: a retrospective cohort study
por: Goossens, Maria (Mieke), et al.
Publicado: (2015)

Agonism and Antagonism at the Insulin Receptor
por: Knudsen, Louise, et al.
Publicado: (2012)

Mammary gland tumor promotion by chronic administration of IGF1 and the insulin analogue AspB10 in the p53(R270H/+)WAPCre mouse model
por: ter Braak, Bas, et al.
Publicado: (2015)

Risk of bladder cancer in patients with diabetes: a retrospective cohort study
por: Goossens, Maria E, et al.
Publicado: (2015)

Modifying Effects of Glucose and Insulin/Insulin-Like Growth Factors on Colon Cancer Cells
por: Berk, Şeyda, et al.
Publicado: (2021)

IGF-I Bioactivity in an Elderly Population: Relation to Insulin Sensitivity, Insulin Levels, and the Metabolic Syndrome
por: Brugts, Michael P., et al.
Publicado: (2010)

The Risk of Fracture in Patients With Multiple Sclerosis: The UK General Practice Research Database
por: Bazelier, Marloes T, et al.
Publicado: (2011)

Risk of Fracture with Thiazolidinediones: Disease or Drugs?
por: Bazelier, Marloes T., et al.
Publicado: (2012)

Insulin, Insulin Resistance, and Platelet Signaling in Diabetes
por: Randriamboavonjy, Voahanginirina, et al.
Publicado: (2009)

Modern insulin and insulin therapy in diabetes mellitus.
por: Montgomery, D. A.
Publicado: (1978)

Management of Individual Patient Expectations When Starting with Highly Effective CFTR Modulators
por: Aalbers, Bente L., et al.
Publicado: (2021)

Risk of Fracture with Thiazolidinediones: An Individual Patient Data Meta-Analysis
por: Bazelier, Marloes T., et al.
Publicado: (2013)

The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma
por: Pivonello, Claudia, et al.
Publicado: (2016)

Therapeutics of Diabetes Mellitus: Focus on Insulin Analogues and Insulin Pumps
por: Valla, Vasiliki
Publicado: (2010)

Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly
por: Varewijck, A. J., et al.
Publicado: (2012)

The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study
por: Elshof, Lotte E., et al.
Publicado: (2017)

Insulin Oedema in Newly Diagnosed Type 1 Diabetes Mellitus
por: Baş, Veysel Nijat, et al.
Publicado: (2010)

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
por: Elshof, Lotte E., et al.
Publicado: (2016)

Insulin
por: Bondy, Philip K.
Publicado: (1961)

Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ
por: Elshof, Lotte E., et al.
Publicado: (2018)

Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus—the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial
por: Lundby-Christensen, Louise, et al.
Publicado: (2016)

The Insulin Treatment of Diabetes Mellitus
Publicado: (1924)

Pancreatic Insulin in Diabetes Mellitus
por: Turtle, John R.
Publicado: (1971)

Defining the Relative Role of Insulin Clearance in Early Dysglycemia in Relation to Insulin Sensitivity and Insulin Secretion: The Microbiome and Insulin Longitudinal Evaluation Study (MILES)
por: Wood, Alexis C., et al.
Publicado: (2021)

Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus
por: Mader, Julia K., et al.
Publicado: (2016)

On the occasion of the centennial of insulin therapy (1922–2022), II-Organotherapy of diabetes mellitus (1906–1923): Acomatol. Pancreina. Insulin.
por: de Leiva-Hidalgo, Alberto, et al.
Publicado: (2022)

Comparison of the Efficacy and Safety of Insulin Glargine and Insulin Detemir with NPH Insulin in Children and Adolescents with Type 1 Diabetes Mellitus Receiving Intensive Insulin Therapy
por: Dündar, Bumin Nuri, et al.
Publicado: (2009)

Homozygous Mutation in the Insulin Receptor Gene Associated with Mild Type A Insulin Resistance Syndrome: A Case Report
por: Hacihamdioğlu, Bülent, et al.
Publicado: (2021)

Regulation of AT1R expression through HuR by insulin
por: Paukku, Kirsi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j5vq554j83aoj6hltf2l0bo1m8